Effect of noscapine and vincristine combination on demyelination and cell proliferation in vitro

References

• Gidding C E, Kellie S J, Kamps W A, DeGraaf S S. Vincristine revisited. Crit Rev Oncol Hematol 1999; 29: 267–287
   PubMed Web of Science ®Google Scholar
• McEvoy G. American Hospital Formulary Service. American Society of Health-System Pharmacists, Bethesda 2004
   Google Scholar
• Barohn R J. Approach to peripheral neuropathy and neuronopathy. Semin Neurol 1998; 18: 7–18
   PubMed Web of Science ®Google Scholar
• Gigant B, Wang C, Ravelli R B, Roussi F, Steinmetz M O, Curmi P A, et al. Structural basis for the regulation of tubulin by vinblastine. Nature 2005; 435: 519–522
   PubMed Web of Science ®Google Scholar
• Zhou J, Panda D, Landen J W, Wilson L, Joshi H C. Minor alteration of microtubule dynamics causes loss of tension across kinetochore pairs and activates the spindle checkpoint. J Biol Chem 2002; 277: 17200–17208
   PubMed Web of Science ®Google Scholar
• Ye K, Ke Y, Keshava N, Shanks J, Kapp J A, Tekmal R R, et al. Opium alkaloid noscapine is an antitumor agent that arrests metaphase and induces apoptosis in dividing cells. Proc Natl Acad Sci USA 1998; 95: 1601–1616
   PubMed Web of Science ®Google Scholar
• Bain G, Ray W J, Yao M, Gottlieb D I. Retinoic acid promotes neural and represses mesodermal gene expression in mouse embryonic stem cells in culture. Biochem Biophys Res Commun 1996; 223: 691–694
   PubMed Web of Science ®Google Scholar
• Allan V J. Basic immunofluorescence. Protein Localization by Fluorescence Microscopy, V J Allan. Oxford University Press, Oxford 2000; 1–26
   Google Scholar
• Hiser L, Aggarwal A, Young R, Frankfurter A, Spano A, Correia J J, et al. Comparison of beta-tubulin mRNA and protein levels in 12 human cancer cell lines. Cell Motil Cytoskeleton 2006; 63: 41–52
   PubMed Web of Science ®Google Scholar
• Chou T C, Motzer R J, Tong Y, Bosl G J. Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: a rational approach to clinical protocol design. J Natl Cancer Inst 1994; 86: 1517–1524
   PubMed Web of Science ®Google Scholar
• Massengale M, Wagers A J, Vogel H, Weissman I L. Hematopoietic cells maintain hematopoietic fates upon entering the brain. J Exp Med 2005; 201: 1579–1589
   PubMed Web of Science ®Google Scholar
• Houghton J A, Williams L G, Torrance P M, Houghton P J. Determinants of intrinsic sensitivity to Vinca alkaloids in xenografts of pediatric rhabdomyosarcomas. Cancer Res 1984; 44: 582–590
   PubMed Web of Science ®Google Scholar
• Ke Y, Ye K, Grossniklaus H E, Archer D R, Joshi H C, Kapp J A. Noscapine inhibits tumor growth with little toxicity to normal tissues or inhibition of immune responses. Cancer Immunol Immunother 2000; 49: 217–225
   PubMed Web of Science ®Google Scholar
• Landen J W, Hau V, Wang M, Davis T, Ciliax B, Wainer B H, et al. Noscapine crosses the blood–brain barrier and inhibits glioblastoma growth. Clin Cancer Res 2004; 10: 5187–5201
   PubMed Web of Science ®Google Scholar
• Tse A N, Rendahl K G, Sheikh T, Cheema H, Aardalen K, Embry M, et al. CHIR-124, a novel potent inhibitor of Chk1, potentiates the cytotoxicity of topoisomerase I poisons in vitro and in vivo. Clin Cancer Res 2007; 13: 591–602
   PubMed Web of Science ®Google Scholar
• Boyle F M, Eller L S, Grossman S A. Penetration of intra-arterially administered vincristine in experimental brain tumor. Neuro Oncol 2004; 6: 300–305
   PubMed Web of Science ®Google Scholar
• De Stefano N, Narayanan S, Francis G S, Arnaoutelis R, Tartaglia M C, Antel J P, et al. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol 2001; 58: 65–70
   PubMed Web of Science ®Google Scholar
• Silva A, Wang Q, Wang M, Ravula S K, Glass J D. Evidence for direct axonal toxicity in vincristine neuropathy. J Peripher Nerv Syst 2006; 11: 211–216
   PubMed Web of Science ®Google Scholar
• Ja'afer F M, Hamdan F B, Mohammed F H. Vincristine-induced neuropathy in rat: electrophysiological and histological study. Exp Brain Res 2006; 173: 334–345
   PubMed Web of Science ®Google Scholar
• Clark E A, Hills P M, Davidson B S, Wender P A, Mooberry S L. Laulimalide and synthetic laulimalide analogues are synergistic with paclitaxel and 2-methoxyestradiol. Mol Pharm 2006; 3: 457–467
   PubMed Web of Science ®Google Scholar
• Giannakakou P, Villalba L, Li H, Poruchynsky M, Fojo T. Combinations of paclitaxel and vinblastine and their effects on tubulin polymerization and cellular cytotoxicity: characterization of a synergistic schedule. Int J Cancer 1998; 75: 57–63
   PubMed Web of Science ®Google Scholar
• Newcomb E W, Lukyanov Y, Schnee T, Ali M A, Lan L, Zagzag D. Noscapine inhibits hypoxia-mediated HIF-1α expression and angiogenesis in vitro: a novel function for an old drug. Int J Oncol 2006; 28: 1121–1130
   PubMed Web of Science ®Google Scholar
• Orr G A, Verdier-Pinard P, McDaid H, Horwitz S B. Mechanisms of Taxol resistance related to microtubules. Oncogene 2003; 22: 7280–7295
   PubMed Web of Science ®Google Scholar
• Cole J S, Messing A, Trojanowski J Q, Lee V M. Modulation of axon diameter and neurofilaments by hypomyelinating Schwann cells in transgenic mice. J Neurosci 1994; 14: 6956–6966
   PubMed Web of Science ®Google Scholar